In the fourth and final part of the series, Daniel Mackiewicz, a multi-skilled operator of sterile manufacturing at GSK Boronia, reflects on how the company has been determined to 'finish strong' as it works towards exiting the site it has occupied for 52 years.
GSK Boronia and the focus on 'finishing strong' for patients
December 14, 2022 Latest NewsBioPharmaBioPharmaDispatch ExecutiveNews of the DayLatest Video
New Stories
-
The consistent failure to speak out is degrading this critical public health program
October 8, 2024 - - Latest News -
New report reveals significant return from investment in adult vaccination
October 8, 2024 - - Latest News -
Mark Butler confirms Norgine's creation of DFMO access program
October 7, 2024 - - Latest News -
UQ spider venom heart drug moves into clinical trials
October 7, 2024 - - Latest News -
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
October 7, 2024 - - Latest News -
CSL welcomes new treatment for high-risk cardiovascular disease to the PBS
October 7, 2024 - - Latest News -
Cyclopharm signs agreement makes major progress with US veterans and defence administrations
October 6, 2024 - - Latest News